Disseminated fusariosis with ecthyma gangrenosum-like lesions in a refractory acute myeloid leukemia patient

Background and Purpose: Fusarium species is an opportunistic mold that causes disseminated infections in immunocompromised patients. Given the high mortality rate of this infection, it is important to make a definite diagnosis when encountering suspected cases. Case report: Herein, we presented a 35-year-old man diagnosed with acute myeloid leukemia with a prolonged febrile neutropenic period and ecthyma gangrenosum-like lesions, along with fungemia and disseminated fusariosis. The patient died despite receiving combination therapy, perhaps due to the nonrecovery of neutrophil. Conclusion: Ecthyma gangrenosum-like lesions due to disseminated fusariosis might be easily misdiagnosed. Consequently, more attention should be paid to the cutaneous lesions in immunocompromised patients.

[1]  K. Prasad,et al.  Clinical and laboratory standards institute versus European committee for antimicrobial susceptibility testing guidelines for interpretation of carbapenem antimicrobial susceptibility results for Escherichia coli in urinary tract infection (UTI) , 2018, Journal of laboratory physicians.

[2]  H. Badali,et al.  Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species , 2018, Antimicrobial Agents and Chemotherapy.

[3]  G. Battista,et al.  Radiologic findings of Fusarium pneumonia in neutropenic patients , 2017, Mycoses.

[4]  L. Rossato,et al.  In vitro synergistic combinations of pentamidine, polymyxin B, tigecycline and tobramycin with antifungal agents against Fusarium spp. , 2016, Journal of medical microbiology.

[5]  J. Meis,et al.  In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis. , 2016, The Journal of antimicrobial chemotherapy.

[6]  A. Tortorano,et al.  Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature , 2016, Mycopathologia.

[7]  I. Kocmanova,et al.  Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis – case report and review of the literature , 2016, Mycoses.

[8]  J. Meis,et al.  Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015 , 2016, Emerging microbes & infections.

[9]  I. Xess,et al.  Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature , 2015, Mycopathologia.

[10]  C. Waalwijk,et al.  ADVANCES IN DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS , 2015 .

[11]  D. Horn,et al.  Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance® registry , 2014, Mycoses.

[12]  L. Pagano,et al.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  Springer-Verlag,et al.  Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[14]  T. Anagnostou,et al.  Fusarium Infection: Report of 26 Cases and Review of 97 Cases From the Literature , 2013 .

[15]  M. P. Molinari,et al.  Galactomannan testing might be useful for early diagnosis of fusariosis. , 2012, Diagnostic microbiology and infectious disease.

[16]  A. Tortorano,et al.  Cross-Reactivity of Fusarium spp. in the Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay , 2011, Journal of Clinical Microbiology.

[17]  J. Garbino,et al.  Invasive fusariosis with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[18]  E. Anaissie,et al.  Fusarium Infections in Immunocompromised Patients , 2007, Clinical Microbiology Reviews.

[19]  E. Chadwick,et al.  Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole. , 2004, The Pediatric infectious disease journal.

[20]  S. de Botton,et al.  Successful Outcome of Disseminated Fusarium Infection with Skin Localization Treated with Voriconazole and Amphotericin B-Lipid Complex in a Patient with Acute Leukemia , 2003, Journal of Clinical Microbiology.

[21]  M. Pfaller,et al.  Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi , 2003, Journal of Clinical Microbiology.

[22]  E. Anaissie,et al.  Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  A. Hasegawa,et al.  Phylogenetic Classification and Species Identification of Dermatophyte Strains Based on DNA Sequences of Nuclear Ribosomal Internal Transcribed Spacer 1 Regions , 1999, Journal of Clinical Microbiology.

[24]  Johnson M Liu,et al.  Invasive Infection with Fusarium chlamydosporum in a Patient with Aplastic Anemia , 1998, Journal of Clinical Microbiology.

[25]  E. Anaissie,et al.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. , 1997, Blood.

[26]  D. Armstrong,et al.  Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma , 1985, Journal of clinical microbiology.